SCN2A Gene Dravet Syndrome Genetic Test
Introduction
The SCN2A gene is one of the genes associated with Dravet syndrome, a rare form of epilepsy that usually begins in infancy or early childhood. Dravet syndrome is characterized by seizures that are often difficult to control with medication, developmental delays, and other neurological symptoms.
Test Components
- Test Name: SCN2A Gene Dravet Syndrome Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Prior to the SCN2A Gene Dravet Syndrome Genetic Test, it is important to gather the clinical history of the patient who is going for the test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with SCN2A Gene Dravet Syndrome.
Test Details
NGS (next-generation sequencing) genetic testing is a type of genetic testing that uses advanced technology to analyze multiple genes at once. This type of testing can be used to identify mutations or changes in the SCN2A gene that may be associated with Dravet syndrome.
NGS genetic testing for Dravet syndrome may be recommended for individuals who have symptoms of the condition or for family members of individuals with a known SCN2A mutation. The test may also be used for prenatal diagnosis in families with a history of Dravet syndrome.
It is important to note that genetic testing for Dravet syndrome is not always conclusive, and a negative test result does not rule out the possibility of the condition. A diagnosis of Dravet syndrome is typically based on a combination of clinical symptoms, family history, and genetic testing results.
Test Name | SCN2A Gene Dravet syndrome Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SCN2A Gene Dravet syndrome NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCN2A Gene Dravet syndrome |
Test Details | The SCN2A gene is one of the genes associated with Dravet syndrome, a rare form of epilepsy that usually begins in infancy or early childhood. Dravet syndrome is characterized by seizures that are often difficult to control with medication, developmental delays, and other neurological symptoms. NGS (next-generation sequencing) genetic testing is a type of genetic testing that uses advanced technology to analyze multiple genes at once. This type of testing can be used to identify mutations or changes in the SCN2A gene that may be associated with Dravet syndrome. NGS genetic testing for Dravet syndrome may be recommended for individuals who have symptoms of the condition, or for family members of individuals with a known SCN2A mutation. The test may also be used for prenatal diagnosis in families with a history of Dravet syndrome. It is important to note that genetic testing for Dravet syndrome is not always conclusive, and a negative test result does not rule out the possibility of the condition. A diagnosis of Dravet syndrome is typically based on a combination of clinical symptoms, family history, and genetic testing results. |